NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS

Yıl 2017, Cilt: Volume 2 Sayı: İssue 1 (1) - 2.İnternational Congress Of Forensic Toxicology, 84 - 84, 16.02.2017

Ludwig Kraus

Öz

Within the past
decade, there has been a significant change in the area of drug use in Europe.
Larger numbers of new psychoactive substances (NPS) have emerged on the market.
The number of new drugs reported to the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) has increased from six new substances in the year
2004 (EMCDDA, 2005) to 101 new substances in 2014 (EMCDDA, 2015). With these
substances come a unique set of risks and problems for the users, emergency personnel,
and prevention and policy makers. The present presentation’s goal is to shed
light on the extent of NPS consumption in Europe as well as the problems and
the risks associated with these substances.

Anahtar Kelimeler

NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE

Kaynakça

• Ludwig KRAUS IFT Institut für Therapieforschung, München, Deutschland; Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm University, Stockholm, Schweden Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm Universität, Stockholm, Schweden